药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Carbetocin
Castanospermine
The risk or severity of adverse effects can be increased when Castanospermine is combined with Teriflunomide.
Carbetocin
Stepronin
The risk or severity of adverse effects can be increased when Stepronin is combined with Teriflunomide.
Carbetocin
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Teriflunomide.
Carbetocin
Paramethasone
The risk or severity of adverse effects can be increased when Paramethasone is combined with Teriflunomide.
Carbetocin
Cortisone acetate
The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Teriflunomide.
Carbetocin
Corticotropin
The risk or severity of adverse effects can be increased when Corticotropin is combined with Teriflunomide.
Carbetocin
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Teriflunomide.
Abatacept
Levoleucovorin
The therapeutic efficacy of Aminopterin can be decreased when used in combination with Levoleucovorin.
Abatacept
Triglu-5-formyl-tetrahydrofolate
The therapeutic efficacy of Aminopterin can be decreased when used in combination with Triglu-5-formyl-tetrahydrofolate.
Abatacept
(6S)-5,6,7,8-tetrahydrofolic acid
The therapeutic efficacy of Aminopterin can be decreased when used in combination with (6S)-5,6,7,8-tetrahydrofolic acid.
Nelarabine
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fidaxomicin.
Nelarabine
(S)-Warfarin
The risk or severity of bleeding can be increased when Fidaxomicin is combined with (S)-Warfarin.
Nelarabine
Diphenadione
The risk or severity of bleeding can be increased when Fidaxomicin is combined with Diphenadione.
Nelarabine
Clorindione
The risk or severity of bleeding can be increased when Fidaxomicin is combined with Clorindione.
Nelarabine
Fluindione
The risk or severity of bleeding can be increased when Fidaxomicin is combined with Fluindione.
Nelarabine
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Fidaxomicin is combined with Ethyl biscoumacetate.
Nelarabine
(R)-warfarin
The risk or severity of bleeding can be increased when Fidaxomicin is combined with (R)-warfarin.
Nelarabine
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Fidaxomicin is combined with 4-hydroxycoumarin.
Nelarabine
Tioclomarol
The risk or severity of bleeding can be increased when Fidaxomicin is combined with Tioclomarol.
Nelarabine
Coumarin
The risk or severity of bleeding can be increased when Fidaxomicin is combined with Coumarin.